These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15223247)

  • 21. Body composition and muscular strength changes after moderate activity: association with matrix metalloproteinase polymorphisms.
    Fiotti N; Deiuri E; Altamura N; De Colle P; Moretti ME; Toigo G; Giansante C
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():83-94. PubMed ID: 19836620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of an inducible nitric oxide synthase gene (NOS2A) polymorphism in a multiple sclerosis population.
    Tajouri L; Martin V; Ovcaric M; Curtain RP; Lea RA; Csurhes P; Pender MP; Griffiths LR
    Brain Res Bull; 2004 Jul; 64(1):9-13. PubMed ID: 15275951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects.
    Demacq C; Vasconcellos VB; Marcaccini AM; Gerlach RF; Silva WA; Tanus-Santos JE
    Clin Chem Lab Med; 2008; 46(1):57-63. PubMed ID: 18194081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinase-9 promoter polymorphisms in Korean patients with systemic lupus erythematosus.
    Lee YJ; Woo M; Nam JH; Baek J; Im CH; Lee EY; Lee EB; Park KS; Song YW
    Hum Immunol; 2008 Jun; 69(6):374-9. PubMed ID: 18571010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm.
    Peters DG; Kassam A; St Jean PL; Yonas H; Ferrell RE
    Stroke; 1999 Dec; 30(12):2612-6. PubMed ID: 10582986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients.
    Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Navabi SJ; Shakiba E; Hassanzadeh N; Pourmotabbed T
    Lupus; 2012 May; 21(6):616-24. PubMed ID: 22323339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNF-alpha promoter polymorphisms in multiple sclerosis: no association with -308 and -238 alleles, but the -857 alleles in associated with the disease in Turkish patients.
    Akcali A; Pehlivan S; Pehlivan M; Sever T; Akgul P; Neyal M
    Int J Immunogenet; 2010 Apr; 37(2):91-5. PubMed ID: 20082645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
    Mirowska-Guzel D; Gromadzka G; Czlonkowski A; Czlonkowska A
    J Neuroimmunol; 2009 Sep; 214(1-2):113-7. PubMed ID: 19628284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
    Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
    Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
    J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interferon gene cluster: a candidate region for MS predisposition? Multiple Sclerosis Study Group.
    Miterski B; Jaeckel S; Epplen JT; Pöhlau D; Hardt C
    Genes Immun; 1999 Sep; 1(1):37-44. PubMed ID: 11197304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-10 promoter polymorphism in multiple sclerosis: association with disease progression.
    Almeras L; Meresse B; Seze J; De Lefranc D; Dubucquoi S; Fajardy I; Vermersch P; Prin L
    Eur Cytokine Netw; 2002; 13(2):200-6. PubMed ID: 12101075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A functional matrix metalloproteinase (MMP)-9 polymorphism modifies plasma MMP-9 levels in subjects environmentally exposed to mercury.
    Jacob-Ferreira AL; Passos CJ; Gerlach RF; Barbosa F; Tanus-Santos JE
    Sci Total Environ; 2010 Sep; 408(19):4085-92. PubMed ID: 20554312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Features of vulnerable plaques and clinical outcome of UA/NSTEMI: Relationship with matrix metalloproteinase functional polymorphisms.
    Fiotti N; Moretti ME; Bussani R; Altamura N; Zamolo F; Gerloni R; Ukovich L; Ober E; Silvestri F; Grassi G; Adovasio R; Giansante C
    Atherosclerosis; 2011 Mar; 215(1):153-9. PubMed ID: 21232745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis.
    de Souza AP; Trevilatto PC; Scarel-Caminaga RM; de Brito RB; Barros SP; Line SR
    J Clin Periodontol; 2005 Feb; 32(2):207-11. PubMed ID: 15691353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Kodama D; Saito M; Matsumoto W; Sabouri AH; Izumo S; Arimura K; Usuku K; Bangham CR; Osame M
    J Neuroimmunol; 2004 Nov; 156(1-2):188-94. PubMed ID: 15465610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction.
    Liu PY; Chen JH; Li YH; Wu HL; Shi GY
    Thromb Haemost; 2003 Jul; 90(1):132-9. PubMed ID: 12876636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
    Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
    J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SH2D2A gene and susceptibility to multiple sclerosis.
    Lorentzen AR; Smestad C; Lie BA; Oturai AB; Akesson E; Saarela J; Myhr KM; Vartdal F; Celius EG; Sørensen PS; Hillert J; Spurkland A; Harbo HF
    J Neuroimmunol; 2008 Jul; 197(2):152-8. PubMed ID: 18554728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
    Okamoto K; Mimura K; Murawaki Y; Yuasa I
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.